Centrosome amplification and the origin of chromosomal instability in breast cancer

被引:86
作者
Salisbury, JL [1 ]
D'Assoro, AB
Lingle, WL
机构
[1] Mayo Clin, Mayo Clin Coll Med, Tumor Biol Program, Rochester, MN 55905 USA
[2] Mayo Clin, Mayo Clin Coll Med, Div Expt Pathol, Rochester, MN USA
关键词
aneuploidy; centriole; cell cycle; mitosis;
D O I
10.1023/B:JOMG.0000048774.27697.30
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The development and progression of aggressive breast cancer is characterized by genomic instability leading to multiple genetic defects, phenotypic diversity, chemoresistance, and poor outcome. Centrosome abnormalities have been implicated in the origin of chromosomal instability through the development of multipolar mitotic spindles. Breast tumor centrosomes display characteristic structural abnormalities, termed centrosome amplification, including: increase in centrosome number and volume, accumulation of excess pericentriolar material, supernumerary centrioles, and inappropriate phosphorylation of centrosome proteins. In addition, breast tumor centrosomes also show functional abnormalities characterized by inappropriate centrosome duplication during the cell cycle and nucleation of unusually large microtubule arrays. These observations have important implications for understanding the mechanisms underlying genomic instability and loss of cell polarity in cancer. This review focuses on the coordination of the centrosome, DNA, and cell cycles in normal cells and their deregulation resulting in centrosome amplification and chromosomal instability in the development and progression of breast cancer.
引用
收藏
页码:275 / 283
页数:9
相关论文
共 102 条
[11]   Managing the centrosome numbers game: from chaos to stability in cancer cell division [J].
Brinkley, BR .
TRENDS IN CELL BIOLOGY, 2001, 11 (01) :18-21
[12]   Centrosome hyperamplification in human cancer: chromosome instability induced by p53 mutation and/or Mdm2 overexpression [J].
Carroll, PE ;
Okuda, M ;
Horn, HF ;
Biddinger, P ;
Stambrook, PJ ;
Gleich, LL ;
Li, YQ ;
Tarapore, P ;
Fukasawa, K .
ONCOGENE, 1999, 18 (11) :1935-1944
[13]   Genomic convergence and suppression of centrosome hyperamplification in primary p53-/- cells in prolonged culture [J].
Chiba, S ;
Okuda, H ;
Mussman, JG ;
Fukasawa, K .
EXPERIMENTAL CELL RESEARCH, 2000, 258 (02) :310-321
[14]   Centrosome amplification and the development of cancer [J].
D'Assoro, AB ;
Lingle, WL ;
Salisbury, JL .
ONCOGENE, 2002, 21 (40) :6146-6153
[15]   Amplified centrosomes in breast cancer: A potential indicator of tumor aggressiveness [J].
D'Assoro, AB ;
Barrett, SL ;
Folk, C ;
Negron, VC ;
Boeneman, K ;
Busby, R ;
Whitehead, C ;
Stivala, F ;
Lingle, WL ;
Salisbury, JL .
BREAST CANCER RESEARCH AND TREATMENT, 2002, 75 (01) :25-34
[16]  
DASSORO A, IN PRESS ONCOGENE, V23, P4068
[17]   CYCLIN-B IS ASSOCIATED WITH CENTROSOMES IN DROSOPHILA MITOTIC CELLS [J].
DEBEC, A ;
MONTMORY, C .
BIOLOGY OF THE CELL, 1992, 75 (02) :121-126
[18]  
Deng CX, 2000, BIOESSAYS, V22, P728
[19]   Pericentrin and γ-tubulin form a protein complex and are organized into a novel lattice at the centrosome [J].
Dictenberg, JB ;
Zimmerman, W ;
Sparks, CA ;
Young, A ;
Vidair, C ;
Zheng, YX ;
Carrington, W ;
Fay, FS ;
Doxsey, SJ .
JOURNAL OF CELL BIOLOGY, 1998, 141 (01) :163-174
[20]   Pericentrin anchors protein kinase A at the centrosome through a newly identified RII-binding domain [J].
Diviani, D ;
Langeberg, LK ;
Doxsey, SJ ;
Scott, JD .
CURRENT BIOLOGY, 2000, 10 (07) :417-420